Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -7.71 % |
3 Month Return | + 10.6 % |
1 Year Return | + 141.83 % |
Market Stats | |
Previous Close | ₹224.54 |
Open | ₹218.00 |
Volume | 93.33K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹735.83Cr |
P/E Ratio | 13.88 |
PEG Ratio | 1.05 |
Market Cap | ₹735.83 Cr |
P/B Ratio | 21.77 |
EPS | 17.09 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 38.26 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹735.83 Cr | 236.62% | 0.91 | ₹55 Cr | ₹575 Cr | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Wanbury Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Wanbury Ltd
Wanbury's standalone net sales for September 2024 reached Rs 161.19 crore, up 11.58% YoY. Net profit increased by 8.91% to Rs 8.02 crore, while EBITDA rose 19.56%. The EPS improved to Rs 2.44. Wanbury shares have delivered significant returns of 42.93% over the last 6 months and 146.61% over the past year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 132.05 Cr → 162.82 Cr (in ₹), with an average increase of 18.9% per quarter
Best in 1 Year
In the last 1 year, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 1 year, WANBURY stock has moved up by 141.8%
FII Holding Up
Foreign Institutions have increased holdings from 0.22% to 1.02% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 2 quarters, 1.04 Cr → 8.02 Cr (in ₹), with an average increase of 87.0% per quarter
Best in 3 Years
In the last 3 years, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Down
Promoters have decreased holdings from 39.79% to 39.77% in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 59.98% to 59.20% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 39.77% | ||
Foreign Institutions | 1.02% | 356.34 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 59.2% | ||
Others | 0% | 6.25 |
Wanbury Ltd in the last 5 years
Lowest (-105.12x)
July 15, 2021
Today (13.88x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (146.91x)
September 29, 2023
Wanbury Ltd’s net profit jumped 8.97% since last year same period to ₹8.02Cr in the Q2 2024-2025. On a quarterly growth basis, Wanbury Ltd has generated 671.15% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Wanbury Ltd is currently in a Bearish trading position according to technical analysis indicators.
Wanbury Ltd (WANBURY) share price today is ₹213.44
Wanbury Ltd is listed on NSE
Wanbury Ltd is listed on BSE
PE Ratio of Wanbury Ltd is 13.88
PE ratio = Wanbury Ltd Market price per share / Wanbury Ltd Earnings per share
Today’s traded volume of Wanbury Ltd(WANBURY) is 93.33K.
Today’s market capitalisation of Wanbury Ltd(WANBURY) is ₹735.83Cr.
Wanbury Ltd(WANBURY | Price |
---|---|
52 Week High | ₹290.2 |
52 Week Low | ₹91 |
Wanbury Ltd(WANBURY) share price is ₹213.44. It is down -26.45% from its 52 Week High price of ₹290.2
Wanbury Ltd(WANBURY) share price is ₹213.44. It is up 134.55% from its 52 Week Low price of ₹91
Wanbury Ltd(WANBURY | Returns |
---|---|
1 Day Returns | -11.1% |
1 Month Returns | -7.71% |
3 Month Returns | 10.6% |
1 Year Returns | 141.83% |